188 related articles for article (PubMed ID: 27600955)
1. In vitro antimicrobial activities of animal-used quinoxaline 1,4-di-N-oxides against mycobacteria, mycoplasma and fungi.
Zhao Y; Cheng G; Hao H; Pan Y; Liu Z; Dai M; Yuan Z
BMC Vet Res; 2016 Sep; 12(1):186. PubMed ID: 27600955
[TBL] [Abstract][Full Text] [Related]
2. Further investigations into the genotoxicity of quinoxaline-di-N-oxides and their primary metabolites.
Liu Q; Zhang J; Luo X; Ihsan A; Liu X; Dai M; Cheng G; Hao H; Wang X; Yuan Z
Food Chem Toxicol; 2016 Jul; 93():145-57. PubMed ID: 27170491
[TBL] [Abstract][Full Text] [Related]
3. The metabolism of carbadox, olaquindox, mequindox, quinocetone and cyadox: an overview.
Liu ZY; Sun ZL
Med Chem; 2013 Dec; 9(8):1017-27. PubMed ID: 23521002
[TBL] [Abstract][Full Text] [Related]
4. Advances in Metabolism and Metabolic Toxicology of Quinoxaline 1,4-Di-N-oxides.
An H; Li Y; Li Y; Gong S; Zhu Y; Li X; Zhou S; Wu Y
Chem Res Toxicol; 2024 Apr; 37(4):528-539. PubMed ID: 38507288
[TBL] [Abstract][Full Text] [Related]
5. The critical role of oxidative stress in the toxicity and metabolism of quinoxaline 1,4-di-N-oxides in vitro and in vivo.
Wang X; Martínez MA; Cheng G; Liu Z; Huang L; Dai M; Chen D; Martínez-Larrañaga MR; Anadón A; Yuan Z
Drug Metab Rev; 2016 May; 48(2):159-82. PubMed ID: 27285897
[TBL] [Abstract][Full Text] [Related]
6. N-oxide reduction of quinoxaline-1,4-dioxides catalyzed by porcine aldehyde oxidase SsAOX1.
Mu P; Zheng M; Xu M; Zheng Y; Tang X; Wang Y; Wu K; Chen Q; Wang L; Deng Y
Drug Metab Dispos; 2014 Apr; 42(4):511-9. PubMed ID: 24440959
[TBL] [Abstract][Full Text] [Related]
7. Determination of marker residues of quinoxaline-1,4-di-N-oxides and its prototype identification by liquid chromatography tandem mass spectrometry.
Li L; Liu R; Liu L; Guo Z; Zhou T; Yang Y; Yang H; He L
Food Chem; 2024 Jun; 442():138395. PubMed ID: 38266409
[TBL] [Abstract][Full Text] [Related]
8. High risk of adrenal toxicity of N1-desoxy quinoxaline 1,4-dioxide derivatives and the protection of oligomeric proanthocyanidins (OPC) in the inhibition of the expression of aldosterone synthetase in H295R cells.
Wang X; Yang C; Ihsan A; Luo X; Guo P; Cheng G; Dai M; Chen D; Liu Z; Yuan Z
Toxicology; 2016 Feb; 341-343():1-16. PubMed ID: 26802905
[TBL] [Abstract][Full Text] [Related]
9. Systematic and Molecular Basis of the Antibacterial Action of Quinoxaline 1,4-Di-N-Oxides against Escherichia coli.
Cheng G; Li B; Wang C; Zhang H; Liang G; Weng Z; Hao H; Wang X; Liu Z; Dai M; Wang Y; Yuan Z
PLoS One; 2015; 10(8):e0136450. PubMed ID: 26296207
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of antimicrobial 2,9,10-trisubstituted-6-oxo-7,12-dihydro-chromeno[3,4-b]quinoxalines.
Kotharkar SA; Shinde DB
Bioorg Med Chem Lett; 2006 Dec; 16(24):6181-4. PubMed ID: 17027265
[TBL] [Abstract][Full Text] [Related]
11. Deoxidation rates play a critical role in DNA damage mediated by important synthetic drugs, quinoxaline 1,4-dioxides.
Wang X; Zhang H; Huang L; Pan Y; Li J; Chen D; Cheng G; Hao H; Tao Y; Liu Z; Yuan Z
Chem Res Toxicol; 2015 Mar; 28(3):470-81. PubMed ID: 25626015
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of 1,2,3-trisubstituted-1,4-dihydrobenzo[g]quinoxaline-5,10-diones and related compounds as antifungal and antibacterial agents.
Tandon VK; Yadav DB; Maurya HK; Chaturvedi AK; Shukla PK
Bioorg Med Chem; 2006 Sep; 14(17):6120-6. PubMed ID: 16806945
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, anti-mycobacterial, anti-trichomonas and anti-candida in vitro activities of 2-substituted-6,7-difluoro-3-methylquinoxaline 1,4-dioxides.
Carta A; Loriga M; Paglietti G; Mattana A; Fiori PL; Mollicotti P; Sechi L; Zanetti S
Eur J Med Chem; 2004 Feb; 39(2):195-203. PubMed ID: 14987828
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel nitrogenous heterocyclic-containing quinoxaline-1,4-di-N-oxides as potent activator of autophagy in M.tb-infected macrophages.
Zhang H; Lu Q; Zhang J; Qu W; Xie S; Huang L; Yuan Z; Pan Y
Eur J Med Chem; 2021 Nov; 223():113657. PubMed ID: 34217060
[TBL] [Abstract][Full Text] [Related]
15. Genotoxicity of quinocetone, cyadox and olaquindox in vitro and in vivo.
Ihsan A; Wang X; Zhang W; Tu H; Wang Y; Huang L; Iqbal Z; Cheng G; Pan Y; Liu Z; Tan Z; Zhang Y; Yuan Z
Food Chem Toxicol; 2013 Sep; 59():207-14. PubMed ID: 23774262
[TBL] [Abstract][Full Text] [Related]
16. Development of quinoxaline 1, 4-dioxides resistance in Escherichia coli and molecular change under resistance selection.
Guo W; Hao H; Dai M; Wang Y; Huang L; Peng D; Wang X; Wang H; Yao M; Sun Y; Liu Z; Yuan Z
PLoS One; 2012; 7(8):e43322. PubMed ID: 22952665
[TBL] [Abstract][Full Text] [Related]
17. An appraisal on synthetic and pharmaceutical perspectives of quinoxaline 1,4-di-N-oxide scaffold.
Agrawal N; Bhardwaj A
Chem Biol Drug Des; 2022 Sep; 100(3):346-363. PubMed ID: 35610776
[TBL] [Abstract][Full Text] [Related]
18. In vitro antitubercular and antimicrobial activities of 1-substituted quinoxaline-2,3(1H,4H)-diones.
Ramalingam P; Ganapaty S; Rao ChB
Bioorg Med Chem Lett; 2010 Jan; 20(1):406-8. PubMed ID: 19962890
[TBL] [Abstract][Full Text] [Related]
19. ROS mediated cytotoxicity of porcine adrenocortical cells induced by QdNOs derivatives in vitro.
Huang XJ; Zhang HH; Wang X; Huang LL; Zhang LY; Yan CX; Liu Y; Yuan ZH
Chem Biol Interact; 2010 May; 185(3):227-34. PubMed ID: 20188712
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo assessment of newer quinoxaline-oxadiazole hybrids as antimicrobial and antiprotozoal agents.
Patel NB; Patel JN; Purohit AC; Patel VM; Rajani DP; Moo-Puc R; Lopez-Cedillo JC; Nogueda-Torres B; Rivera G
Int J Antimicrob Agents; 2017 Sep; 50(3):413-418. PubMed ID: 28687457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
